☆ 4.8 Letter

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Get Full Text
Add to Collection

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 386, Issue 15, Pages 1475-1477

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2201933

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. Center for Research on Influenza Pathogenesis [HHSN272201400008C, 75N93021C00014]
  2. National Institute of Allergy and Infectious Diseases
  3. Japan Agency for Medical Research and Development [JP20fk0108412, JP21fk0108615, JP21fk0108104, JP20nk0101632, JP21wm0125002]
  4. Ministry of Health, Labor, and Welfare, Japan [20HA2007]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.